Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence for Histopathological Classification and Recurrence Prediction of Thymic Epithelial Tumors

NCT06301945 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06301945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06301945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence for Histopathological Classification and Recurrence Prediction of Thymic Epithelial Tumors
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2023
Completion date
August 1, 2027
Enrollment
1,020 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thymic carcinoma, thymic epithelial tumor, thymoma, thymoma and thymic carcinoma